高级检索
当前位置: 首页 > 详情页

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.

文献详情

资源类型:
Pubmed体系:
机构: [1]State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China. [2]Chongqing University Cancer Hospital & Chongqing Cancer Hospital, Chongqing, China. [3]Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China. [4]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [5]The General Hospital of Chinese People's Liberation Army, Beijing, China. [6]The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui, China. [7]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China. [8]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. [9]Second Affiliated Hospital of Nanchang University, Nanchang, China. [10]Beijing Hospital, National Geriatric Medical Center, Beijing, China. [11]Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. [12]Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. [13]Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China. [14]Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, China. [15]Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, China. [16]Xijing Hospital of Fourth Military Medical University, Xi'an, China. [17]Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China. [18]The Fifth Medical Center of PLA General Hospital, Beijing, China. [19]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China. [20]Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. [21]Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [22]State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China. medata@163.com. [23]State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China. yexiong12@163.com.
出处:
ISSN:
语种:
PubmedID:
中科院分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 2 区 血液学 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 血液学 2 区 肿瘤学
第一作者:
第一作者机构: [1]State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号